Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neurofibroma trial results

Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

NCT07102394

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +20 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Recruiting

Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

NCT05199376

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, +8 more
Locations: Centre Leon Berard Lyon, France

View Trial Details

Completed

Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1

NCT00314119

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT06322342

Conditions: Acoustic Neuroma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +61 more
Locations: Yale New Haven Hospital New Haven, Connecticut, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Brigham & Women's Hospital Boston, Massachusetts, United States

University of Missouri Columbia, Missouri, United States

View Trial Details

Completed

Stereotactic Body Radiotherapy for Spine Tumors

NCT01347307

Conditions: Arteriovenous Malformations, Benign Spinal Tumors, Cardiovascular Abnormalities, +31 more
Locations: Mercy Medical Center, St. Louis St Louis, Missouri, United States

View Trial Details

Completed

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

NCT01031901

Conditions: Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations: The University of Texas Health Science Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Natural History Study of Patients With Neurofibromatosis Type I

NCT00924196

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

NCT03820778

Conditions: Atypical Neurofibroma, Atypical Neurofibromatosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more
Locations: Children's National Health System Washington D.C., District of Columbia, United States

View Trial Details

Neurofibroma

Neurofibroma trial results

Related conditions